Search Results - "Kivikko, M"

Levosimendan meta-analyses: Is there a pattern in the effect on mortality? by Pollesello, P, Parissis, J, Kivikko, M, Harjola, V.-P

“…Abstract Background Levosimendan is an inodilator developed for treatment of acute heart failure and other cardiac conditions where the use of an inodilator is…”
Get full text

Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure by Nikolaou, Maria, Parissis, John, Yilmaz, M Birhan, Seronde, Marie-France, Kivikko, Matti, Laribi, Said, Paugam-Burtz, Catherine, Cai, Danlin, Pohjanjousi, Pasi, Laterre, Pierre-François, Deye, Nicolas, Poder, Pentti, Cohen-Solal, Alain, Mebazaa, Alexandre

“…The aim of this study was to assess the prevalence of abnormal liver function tests (LFTs) and the associated clinical profile and outcome(s) in acute…”
Get full text

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application by Bouchez, S., Fedele, F., Giannakoulas, G., Gustafsson, F., Harjola, V.-P., Karason, K., Kivikko, M., von Lewinski, D., Oliva, F., Papp, Z., Parissis, J., Pollesello, Piero, Pölzl, G., Tschöpe, C.

“…Levosimendan, a calcium sensitizer and potassium channel-opener, is widely appreciated by many specialist heart failure practitioners for its effects on…”
Get full text

Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion by Toller, W, Heringlake, M, Guarracino, F, Algotsson, L, Alvarez, J, Argyriadou, H, Ben-Gal, T, Černý, V, Cholley, B, Eremenko, A, Guerrero-Orriach, J.L, Järvelä, K, Karanovic, N, Kivikko, M, Lahtinen, P, Lomivorotov, V, Mehta, R.H, Mušič, Š, Pollesello, P, Rex, S, Riha, H, Rudiger, A, Salmenperä, M, Szudi, L, Tritapepe, L, Wyncoll, D, Öwall, A

“…Abstract In cardiac surgery, postoperative low cardiac output has been shown to correlate with increased rates of organ failure and mortality. Catecholamines…”
Get full text

Levosimendan: current data, clinical use and future development by Nieminen, M S, Fruhwald, S, Heunks, L M A, Suominen, P K, Gordon, A C, Kivikko, M, Pollesello, P

“…Levosimendan is an inodilator indicated for the short-term treatment of acutely decompensated severe chronic heart failure, and in situations where…”
Get full text

Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure by Lilleberg, J., Laine, M., Palkama, T., Kivikko, M., Pohjanjousi, P., Kupari, M.

“…Aims: To determine the duration of haemodynamic and neurohormonal action of a 24-h infusion of levosimendan in heart failure. Methods and results: This was a…”
Get full text

Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus by Nieminen, M.S, Altenberger, J, Ben-Gal, T, Böhmer, A, Comin-Colet, J, Dickstein, K, Édes, I, Fedele, F, Fonseca, C, García-González, M.J, Giannakoulas, G, Iakobishvili, Z, Jääskeläinen, P, Karavidas, A, Kettner, J, Kivikko, M, Lund, L.H, Matskeplishvili, S.T, Metra, M, Morandi, F, Oliva, F, Parkhomenko, A, Parissis, J, Pollesello, P, Pölzl, G, Schwinger, R.H.G, Segovia, J, Seidel, M, Vrtovec, B, Wikström, G

“…Abstract Background The intravenous inodilator levosimendan was developed for the treatment of patients with acutely decompensated heart failure. In the last…”
Get full text

Pharmaco-economics of levosimendan in cardiology: A European perspective by Nieminen, M.S, Buerke, M, Parissis, J, Ben-Gal, T, Pollesello, P, Kivikko, M, Karavidas, A, Severino, P, Comín-Colet, J, Wikström, G, Fedele, F

“…Abstract Introduction Heart failure places a significant economic burden on health care. Acute heart failure requires hospitalization and often frequent…”
Get full text

Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure by Kivikko, M, Lehtonen, L

“…Levosimendan is a new calcium sensitizer developed for the treatment of congestive heart failure. Experimental studies indicate that levosimendan increases…”
Get more information

Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure by Kivikko, M, Antila, S, Eha, J, Lehtonen, L, Pentikäinen, P J

“…Levosimendan is a new calcium sensitizer with additional vasodilatory properties developed for the short-term intravenous treatment of congestive heart…”
Get more information

Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper by Farmakis, Dimitrios, Alvarez, Julian, Gal, Tuvia Ben, Brito, Dulce, Fedele, Francesco, Fonseca, Candida, Gordon, Anthony C, Gotsman, Israel, Grossini, Elena, Guarracino, Fabio, Harjola, Veli-Pekka, Hellman, Yaron, Heunks, Leo, Ivancan, Visnja, Karavidas, Apostolos, Kivikko, Matti, Lomivorotov, Vladimir, Longrois, Dan, Masip, Josep, Metra, Marco, Morelli, Andrea, Nikolaou, Maria, Papp, Zoltán, Parkhomenko, Alexander, Poelzl, Gerhard, Pollesello, Piero, Ravn, Hanne Berg, Rex, Steffen, Riha, Hynek, Riksten, Sven-Erik, Schwinger, Robert H.G, Vrtovec, Bojan, Yilmaz, M. Birhan, Zielinska, Marzenna, Parissis, John

“…Abstract Levosimendan is a positive inotrope with vasodilating properties (inodilator) indicated for decompensated heart failure (HF) patients with low cardiac…”
Get full text

OP01-1 - Preoperative treatment with levosimendan in CABG surgery: data from the LEVO-CTS and LICORN studies by Cholley, Bernard, Caruba, T., Chatellier, G., Toller, W., Pollesello, P., Kivikko, M., Sarapohja, T., Heringlake, M.

Get full text

Preoperative treatment with levosimendan in CABG surgery: data from the LEVO-CTS and LICORN studies by Cholley, Bernard, Caruba, T., Chatellier, G., Toller, W., Pollesello, P., Kivikko, M., Sarapohja, T., Heringlake, M.

Get full text

Sustained hemodynamic effects of intravenous levosimendan by KIVIKKO, Matti, LEHTONEN, Lasse, COLUCCI, Wilson S

“…The short-term infusion of levosimendan (Levo) improves hemodynamic function in patients with decompensated heart failure. The metabolites of Levo have a…”
Get full text

Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practice: German Base Case by Hendrich, J, Mardiguian, S, Smare, C, Bertranou, E, Kivikko, M, Lattila, T

Get full text

PCV93 - Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practice: German Base Case by Hendrich, J, Mardiguian, S, Smare, C, Bertranou, E, Kivikko, M, Lattila, T

Get full text

Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study by Kivikko, Matti, MD, PhD, Kuoppamäki, Mikko, MD, PhD, Soinne, Lauri, MD, PhD, Sundberg, Stig, PhD, Pohjanjousi, Pasi, MSc, Ellmen, Juha, PhD, Roine, Risto O., MD, PhD

“…Abstract Background Intravenous levosimendan is indicated for acute heart failure. The compound has shown promising beneficial effects in ischemic stroke…”
Get full text

Renal Effects of Levosimendan: A Consensus Report by Yilmaz, Mehmet B., Grossini, Elena, Silva Cardoso, José C., Édes, István, Fedele, Francesco, Pollesello, Piero, Kivikko, Matti, Harjola, Veli-Pekka, Hasslacher, Julia, Mebazaa, Alexandre, Morelli, Andrea, le Noble, Jos, Oldner, Anders, Oulego Erroz, Ignacio, Parissis, John T., Parkhomenko, Alexander, Poelzl, Gerhard, Rehberg, Sebastian, Ricksten, Sven-Erik, Rodríguez Fernández, Luís M., Salmenperä, Markku, Singer, Mervyn, Treskatsch, Sascha, Vrtovec, Bojan, Wikström, Gerhard

“…Renal dysfunction is common in clinical settings in which cardiac function is compromised such as heart failure, cardiac surgery or sepsis, and is associated…”
Get full text

Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure by Kivikko, Matti, Antila, Saila, Eha, Jaan, Lehtonen, Lasse, Pentikäinen, Pertti J.

“…Levosimendan is a new calcium sensitizer developed for the short‐term intravenous treatment of congestive heart failure. The aims of the present open‐label,…”
Get full text

Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan by Antila, Saila, Kivikko, Matti, Lehtonen, Lasse, Eha, Jaan, Heikkilä, Aira, Pohjanjousi, Pasi, Pentikäinen, Pertti J.

“…Aims The purpose of the study was to characterize the pharmacokinetics of levosimendan and its metabolites OR‐1855 and OR‐1896 in patients with congestive…”
Get full text